ALARIS Medical Announces Appointment of Frederic Denerolle as Vice President and General Manager of Its International Business Unit.

Business Editors & Health/Medical Writers

SAN DIEGO--(BW HealthWire)--March 21, 2001

Realignment of Other Officer Responsibilities also Outlined

ALARIS Medical Inc. (AMEX:AMI) announced today that Frederic Denerolle has been appointed vice president and general manager of the International Business Unit of its operating subsidiary, ALARIS Medical Systems Inc., headquartered in Basingstoke, England.

He replaces Henk van Rossem who left the company last year. Denerolle's appointment was effective Jan. 8, 2001.

Over the past 15 years, Denerolle has held increasingly responsible leadership positions in well-known International medical device companies. In particular, he has been intimately involved in the drug infusion device business in France and Germany, the latter being the world's third largest healthcare consumer market. An experienced general manager, he was most recently the executive vice president/general manager of Fresenius' Infusion Technology Division.

Denerolle is a graduate in Business Administration from Ecole Superieure de Commerce de Nantes, which included MBA course work at Bowling Green State University.

David L. Schlotterbeck, president and chief executive officer, commented, "We are pleased that Frederic has joined us as the head of our international business unit. His knowledge of the international medical device market in general and the infusion device market in particular positions him well to make a major contribution to the success of ALARIS Medical Systems and our customers."

Schlotterbeck also indicated that he has realigned the responsibilities of several other corporate officers. Sally M. Grigoriev has been appointed vice president -- operations, with worldwide responsibility for manufacturing, sourcing and distribution of ALARIS Medical Systems' products. She replaces Joergen Lyngsgaard, who will be leaving the company on March 30. Grigoriev, who has been with the company since 1995, was previously vice president -- regulatory affairs and quality assurance. That position has been filled by the promotion of William H. Murphy, formerly director of regulatory affairs for the company. Murphy is a seasoned executive with many years of experience not only in QA/RA but also in Operations and R&D. He has a BS degree from Augusta College in Georgia, has presented to the Food and Drug Law Institute, and has held senior leadership positions in leading medical device manufacturers including The Kendall Company, Hudson RCI and Nellcor Puritan Bennett.

ALARIS Medical Inc., through its operating company, ALARIS Medical Systems Inc., is known for its IMED(R) and IVAC(R) brand names of intravenous infusion therapy systems and patient monitoring products. The company's principal line of business is the design, manufacture and marketing of intravenous infusion therapy products, patient monitoring instruments and related disposables. The company's products are distributed to more than 120 countries worldwide. In addition to its San Diego world headquarters and manufacturing facility, the company also operates manufacturing facilities in Creedmoor, N.C.; Basingstoke, Hampshire, U.K.; and Tijuana, Mexico. Additional information on ALARIS Medical can be found at www.alarismed.com.